Zadeh, G., Daras, M., Cloughesy, T. F., Colman, H., Kumthekar, P. U., Chen, C. C., Aiken, R., Groves, M. D., Ong, S., Ramakrishna, R., Vogelbaum, M. A., Khagi, S., Kaley, T., Melear, J. M., Peereboom, D. M., Rodriguez, A., Yankelevich, M., Nair, S. G., Puduvalli, V. K., Nassiri, F., Sonabend, A. M., Agensky, L., Ewald, B., Levisetti, M., & Lang, F. F. (n.d.). lTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192). Neuro-oncology, 22, ii237. http://access.bl.uk/ark:/81055/vdc_100116592905.0x000020